If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email email@example.com .
Please tell us what format you need. It will help us if you say what assistive technology you use.
Increasing resistance and a lack of new drugs means a greater risk of infections that cannot be treated. This will make routine medical care riskier and result in more deaths so antimicrobial resistance (AMR) affects us all.
The overall goal of this new cross-government UK strategy is to slow the development and spread of antimicrobial resistance by focusing activities around 3 strategic aims.
improve the knowledge and understanding of antimicrobial resistance
conserve and steward the effectiveness of existing treatments
stimulate the development of new antibiotics, diagnostics and novel therapies
The strategy confirms the UK’s leading role in stimulating national and international action on this global issue and it is important that all sectors respond to the call for action if we are to successfully address this issue.